Trial Profile
A study evaluating effect of testosterone treatment on hypogonadal men with type II diabetes and prediabetes: A controlled registry study.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 06 Oct 2017
Price :
$35
*
At a glance
- Drugs Testosterone undecanoate (Primary)
- Indications Hypogonadism
- Focus Pharmacodynamics
- 06 Oct 2017 New trial record
- 15 Sep 2017 Results of 8-year data presented at the 53rd Annual Meeting of the European Association for the Study of Diabetes